The Bay Area's biotech market has landed one of its largest deals to date with a trio of dispositions Alexandria Real Estate Equities made that collectively tallied nearly $400 million.
The Bay Area's biotech market has landed one of its largest deals to date with a trio of dispositions Alexandria Real Estate Equities made that collectively tallied nearly $400 million.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Finance and Insurance